Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
Reported today (16 July 2018) in the journal Nature Biotechnology, the study also revealed that standard tests for detecting DNA changes miss finding this genetic damage, and that caution and specific testing will be required for any potential gene therapies.
CRISPR/Cas9 is one of the newest genome editing tools. It can alter sections of DNA in cells by cutting at specific points and introducing changes at that location. Already extensively used in scientific research, CRISPR/Cas9 has also been seen as a promising way to create potential genome editing treatments for diseases such as HIV, cancer or sickle cell disease. Such therapeutics could inactivate a disease-causing gene, or correct a genetic mutation. However, any potential treatments would have to prove that they were safe.
Previous research had not shown many unforeseen mutations from CRISPR/Cas9 in the DNA at the genome editing target site. To investigate this further the researchers carried out a full systematic study in both mouse and human cells and discovered that CRISPR/Cas9 frequently caused extensive mutations, but at a greater distance from the target site.
The researchers found many of the cells had large genetic rearrangements such as DNA deletions and insertions. These could lead to important genes being switched on or off, which could have major implications for CRISPR/Cas9 use in therapies. In addition, some of these changes were too far away from the target site to be seen with standard genotyping methods.
“This is the first systematic assessment of unexpected events resulting from CRISPR/Cas9 editing in therapeutically relevant cells, and we found that changes in the DNA have been seriously underestimated before now. It is important that anyone thinking of using this technology for gene therapy proceeds with caution, and looks very carefully to check for possible harmful effects.”
Professor Allan Bradley, corresponding author on the study from the Wellcome Sanger Institute
“My initial experiment used CRISPR/Cas9 as a tool to study gene activity, however it became clear that something unexpected was happening. Once we realised the extent of the genetic rearrangements we studied it systematically, looking at different genes and different therapeutically relevant cell lines, and showed that the CRISPR/Cas9 effects held true.”
Michael Kosicki, the first author from the Wellcome Sanger Institute
The work has implications for how CRISPR/Cas9 is used therapeutically and is likely to re-spark researchers’ interest in finding alternatives to the standard CRISPR/Cas9 method for gene editing.
“This study is the first to assess the repertoire of genomic damage arising at a CRISPR/Cas9 cleavage site. While it is not known if genomic sites in other cell lines will be affected in the same way, this study shows that further research and specific testing is needed before CRISPR/Cas9 is used clinically.”
Professor Maria Jasin, an independent researcher from Memorial Slone Kettering Cancer Centre, New York, who was not involved in the study
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
The CRISPR Tug of War
on August 17, 2018 at 10:05 am
“These parties are currently engaged in litigation over patents concerning the potentially most lucrative application of CRISPR technology – the use of CRISPR-Cas9 in plant and animal (eukaryotic) cel... […]
Flexible & Precise Control Of Gene Expression
on August 17, 2018 at 3:07 am
Leveraging a CRISPR-Cas9 system for targeted integration of a polyA track at a precise location within the targeted gene, our kits are custom-designed for your project and include everything you need ... […]
The Battle For Best-In-Class In ATTR Has Begun
on August 16, 2018 at 8:58 am
Additional preclinical competition includes Intellia's (NASDAQ: NTLA) CRISPR-Cas9 approach. In transthyretin amyloidosis, the protein transthyretin (TTR) aggregates to form insoluble amyloid fibrils. ... […]
Organic Times: New satire site takes Onion-like look at crop biotechnology activists
on August 16, 2018 at 5:18 am
While farmers in the developing world struggle to save their crops from pest invasions and courts and judges determine the fate of critical farming tools like the herbicide glyphosate in the US and th... […]
Improving CRISPR-Cas9’s Rate of Homology-Directed Repair
on August 14, 2018 at 12:49 pm
In recent years, CRISPR-Cas9 genome editing has enjoyed spectacular success because it combines flexibility and usability. The Cas9 nuclease need only be loaded with a guide RNA to direct it to almost ... […]
CRISPR/Cas9 players give up gains on (another) report of off-target effects
on August 9, 2018 at 4:11 pm
The research paper rollercoaster continues for CRISPR/Cas9 gene editors Editas Medicine (EDIT +3.1%), CRISPR Therapeutics (CRSP +2%) and Intellia Therapeutics (NTLA +2%). All have retraced the bulk of ... […]
New technology improves CRISPR-Cas9 gene editing in mosquitoes, other species
on August 9, 2018 at 3:53 pm
Using a newly developed method to deliver gene-editing material to the ovary of an adult mosquito, researchers disabled a gene that caused its offspring on the right to be born with white, rather than ... […]
In-depth Analysis of CRISPR/Cas9 Technology 2016-2025 - ResearchAndMarkets.com
on August 8, 2018 at 9:10 am
DUBLIN--(BUSINESS WIRE)--The "In-depth Analysis- CRISPR/Cas9 Technology" report has been added to ResearchAndMarkets.com's offering. The report studies the analysis and multidimensional technical cate... […]
Yield10 Bioscience Signs Research License Agreement Covering CRISPR-Cas9 Genome-Editing Technology with the Broad Institute and Pioneer
on August 8, 2018 at 5:30 am
WOBURN, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food s... […]
via Bing News